Synmosa Biopharma Corporation (TPEX:4114)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
36.95
+0.60 (1.65%)
Jul 24, 2025, 12:59 PM CST

Synmosa Biopharma Company Description

Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches, develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand in Taiwan.

The company offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology.

The company also provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, sex hormones, and other forms.

In addition, it offers contract manufacturing services. The company also exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, and other countries.

Synmosa Biopharma Corporation was founded in 1970 and is based in Taipei, Taiwan.

Synmosa Biopharma Corporation
CountryTaiwan
Founded1970
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
CEOChih-Hui Lin

Contact Details

Address:
No. 396 Neihu Road
Taipei, 114
Taiwan
Phone886 2 8797 7100
Websitesynmosa.com.tw

Stock Details

Ticker Symbol4114
ExchangeTaipei Exchange
Stock TypeCommon Stock
Fiscal YearJanuary - December
Reporting CurrencyTWD
ISIN NumberTW0004114004
SIC Code2834

Key Executives

NamePosition
Chih-Hui LinChairman, GM, Managerial Officer and President
Hong-Qin BaiSenior Vice President and Finance Officer
Jia-Xin ZhangSenior Vice President
Sheng-Ren YangSenior Vice President
Liyu HuangChief Financial Officer
Ching-Hua TsaoAccounting Officer
Zen YoungVice President of Sales - HP, Marketing and Medical